• Profile

Management of gynaecological cancers during COVID-19

M3 India Newsdesk Jun 26, 2020

How should you manage cases of gynaecological cancers amid the ongoing pandemic? While not every case may be urgent, if you have been seeking answers for such questions, read on to know the recommendations published in a review article for the Cancer Research, Statistics, and Treatment journal.

For our comprehensive coverage and latest updates on COVID-19 click here.

The COVID-19 pandemic has posed infinite challenges for hospitals, doctors, researchers and patients alike. What is worse is no one knows when problems related to the pandemic will end. In such a situation, management of cancer cases becomes difficult as on the one hand it is not ideal to postpone cancer treatment, but is it worth exposing patients to the risk of contracting the new coronavirus? No one has answers, at least there are still no guidelines available to help clinicians make decisions.

Dessai S. et. al. recently published their recommendations for specifically guiding gynaecological oncologists on how to handle their cases in the Indian scenario. [1] Here we present highlights from their article ‘Management of patients with gynaecological cancers during the COVID‑19 pandemic’, which was carried in the Cancer Research, Statistics, and Treatment journal.

Ajax loader
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen